Obesity treatment awareness boosts interest in Zealand Pharma's pipeline
”We are not feeling pressured into entering a partnership,” says Zealand Pharma CEO Adam Steensberg, although he’s ready to pounce if the right opportunity arises.
by christopher due karlsson, translated by daniel pedersen
Medical treatment for obesity is garnering interest these days, and the increased awareness can be felt by Zealand Pharma, which has several potential obesity medicines under development according to the company’s CEO, Adam Steensberg.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
